Immunitybio Inc

IBRX

NASDAQ. Currency in USD

5.72 -0.72 ( -11.18% )

Real time prices: December 19

Market Cap.
2.29B
Beta (5Y monthly)
-
Price/Earnings
-
EPS (TTM)
-1.01
Forward Dividend
0.00 (0.00%)
Ex-Dividend Date
Volume
1.77M
1y Target Est.
9.00
Day's Range
5.71
-
6.47
52 Week's Range
2.60
-
7.85

Historical Summary

Performance
EPS growth
Share Buybacks

About Immunitybio Inc

Sector
Healthcare
Industry
Biotechnology
Website
https://immunitybio.com
Exchange
NASDAQ (XNAS)
Shares Outstanding
397.60M
Employees
760
Address
3530 John Hopkins Court, San Diego, CA, United States, 92121
ImmunityBio, Inc., a clinical-stage biotechnology company, engages in developing therapies and vaccines that complement, harness, and amplify the immune system to defeat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The company also develops therapeutic agents, which are in Phase II or III clinical trial for the treatment of liquid and solid tumors, including bladder, pancreatic, and lung cancers, as well as pathogens as SARS-CoV-2 and HIV. It has collaboration agreements with National Cancer Institute, National Institute of Deafness and Communication Disorders, and Amyris, Inc.; and license agreements with CytRx Corporation, EnGeneIC Pty Limited, GlobeImmune, Inc., and Infectious Disease Research Institute, Sanford Health, Shenzhen Beike Biotechnology Co. Ltd., Sorrento Therapeutics, Inc., and Viracta Therapeutics, Inc. The company was founded in 2014 and is based in San Diego, California.

Latest news

Worthington Industries, CarMax And Other Big Losers From Thursday
Worthington Industries, CarMax And Other Big Losers From Thursday

U.S. stocks closed lower with the Nasdaq Composite dropping more than 300 points on Thursday....
By Benzinga - 18 weeks ago

Nikola, Super Micro Computer And Other Big Losers From Monday
Nikola, Super Micro Computer And Other Big Losers From Monday

U.S. stocks closed higher with the Dow Jones gaining around 197 points on Monday. Here...
By Benzinga - 19 weeks ago

Why KnowBe4 Shares Jumped Over 28%; Here Are 79 Biggest Movers From Yesterday
Why KnowBe4 Shares Jumped Over 28%; Here Are 79 Biggest Movers From Yesterday

Gainers Ventoux CCM Acquisition Corp. (NASDAQ: VTAQ) shares jumped 54.6% to settle at $7.05 on...
By Benzinga - 19 weeks ago

Why Virios Therapeutics Is Trading Lower By Over 71%, Here Are 55 Stocks Moving In Monday's Mid-Day Session
Why Virios Therapeutics Is Trading Lower By Over 71%, Here Are 55 Stocks Moving In Monday's Mid-Day Session

Gainers MicroCloud Hologram Inc. (NASDAQ: HOLO) shares jumped 134.6% to $19.74. BYND Cannasoft Enterprises Inc....
By Benzinga - 19 weeks ago

Why Adobe Is Trading Lower By 17%, Here Are 49 Stocks Moving In Thursday's Mid-Day Session
Why Adobe Is Trading Lower By 17%, Here Are 49 Stocks Moving In Thursday's Mid-Day Session

Gainers HeartBeam, Inc. (NASDAQ: BEAT) shares surged 58% to $1.96 after the company announced its...
By Benzinga - 20 weeks ago

Why Vintage Wine Estates Shares Tumbled 40%; Here Are 70 Biggest Movers From Yesterday
Why Vintage Wine Estates Shares Tumbled 40%; Here Are 70 Biggest Movers From Yesterday

Gainers AMTD Digital Inc. (NYSE: HKD) shares jumped 311.8% to settle at $189.42 on Wednesday...
By Benzinga - 20 weeks ago

Twilio, AMTD Digital And Other Big Gainers From Wednesday
Twilio, AMTD Digital And Other Big Gainers From Wednesday

U.S. stocks closed mostly higher with the Nasdaq 100 gaining around 100 points on Wednesday....
By Benzinga - 20 weeks ago

LAVA Therapeutics N.V. (LVTX) Reports Q2 Loss, Lags Revenue Estimates
LAVA Therapeutics N.V. (LVTX) Reports Q2 Loss, Lags Revenue Estimates

LAVA Therapeutics N.V. (LVTX) delivered earnings and revenue surprises of 49.18% and 53.20%, respectively, for...
By Zacks Investment Research - 20 weeks ago